Home Page
Chairman's Letter
Committees
Opening Lectures
International Society of Heart
Failure Awards

Thanks

General Information
Social Program
List of Exhibitors
Scientific Program
Satellite Symposium
Monday, July 10, 2000
Registration Form
Accommodation
Form (Word Document)
Back to CARDIOLOGY ONLINE
  SCIENTIFIC PROGRAM

MONDAY,
JULY 10, 2000

TUESDAY, 
JULY 11, 2000

WEDNESDAY,
JULY 12, 2000

 

MONDAY, JULY 10, 2000
09:00-09:30    HALL A
OC:  OPENING CEREMONY
Chairperson: U. Elkayam, Los Angeles CA, USA
 
09:00  GREETINGS

Asher Kimchi, USA
Founder and Chairman
International Society of Heart Failure
7th World Congress of Heart Failure

Pawan K. Singal, Canada
Member Scientific Executive Committee
Chairman, Section of Basic Research
International Society of Heart Failure
7th World Congress on heart Disease

Mihai Gheorghiade, USA
Member, Scientific Executive Committee
Chairman, Section of Coronary Artery Disease
International Society of Heart Failure
7th World Congress on heart Disease

John A. Elefteriades, USA
Member, Scientific Executive Committee
Chairman, Section of Cardiac Surgery
International Society of Heart Failure
7th World Congress on Heart Failure

 
  PRESENTATION OF 2000 AWARDS
Uri Elkayam, USA
Chairman, Scientific Executive Committee
Chairman, Awards Committee
Chairman, Section of Clinical Trials
International Society of Heart Failure
7th World Congress on Heart Failure
 
MONDAY, JULY 10, 2000
09:30-10:15   HALL A
OL:  OPENING LECTURE
Chairperson: A.J. Tajik, Rochester MN, USA 
 
    Abstract Page
 09:30  INTRODUCTION
A.J. Tajik, Rochester MN, USA
Member, Scientific Executive Committee
International Society of Heart Failure
7th World Congress on Heart Failure
 
 09:35  THOMAS W. SMITH MEMORIAL LECTUTE:
THE CELLULAR AND MOLECULAR BASIS OF HEART FAILURE IN VALVULAR REGURGITATION: RELATION TO CLINICAL OUTCOME (Opening Lecture)
J.F. Borer, New York NY, USA
  1
 10:15  Coffee Break  
MONDAY, JULY 10, 2000
10:45-12:45   HALL A
PL01:  Plenary Session:
MOLECULAR BIOLOGY AND GENETIC STUDIES
Chairpersons: J.S. Borer, New York NY, USA R.A. Trent, Campentown NSW, Australia
 
    Abstract Page
 10:45  THE GENETICS OF CARDIOMYOPATHY (Invited Lecture)
R.J.A. Trent, Sydney NSW, Australia
  1
 11:00  ALTERED PHENOTYPE PATTERN UNDERLYING CONTRACTILE DYSFUNCTION IN FAILING HUMAN MYOCARDIUM (Invited Lecture)
B. Pieske, Goettingen, Germany
  1
11:15  SUBCELLULAR REMODELING DURING THE DEVELOPMENT OF CONGESTIVE HEART FAILURE (Invited Lecture)
N.S. Dhalla, Winnipeg MB, Canada 
1
11:30  MOLECULAR MECHANISM OF APOPTOSIS IN HEART (Invited Lecture)
S. Mustapha, O. Zlouzina, D. de Moissac, L.A. Kirshenbaum, Winnipeg MB, Canada 
2
 11:45  APOPTOSIS AND HEART FAILURE - MECHANISMS AND NEW THERAPEUTIC STRATEGIES (Invited Lecture)
G.Z. Feuerstein, Wilmington DE, USA
  2
 12:00  G PROTEIN-COUPLED RECEPTOR KINASES IN THE HEART: ANIMAL MODELS AND THERAPEUTIC IMPLICATIONS (Invited Lecture)
W.J. Koch, Durham NC, USA 
 2
 12:15  MODULATION OF ISCHEMIC MYOCARDIAL DYSFUNCTION BY BETA-ONE ADRENOCEPTOR ANTISENSE (Invited Lecture)
J.L. Mehta, H.J. Chen, D.Y. Li, Gainesville FL, USA 
 2
 12:30  Lunch Break  
MONDAY, JULY 10, 2000
10:45-13:00   HALL B
PL02:  Plenary Session:
NEW DEVELOPMENTS IN CARDIAC IMAGING
Chairpersons: A.P. Furnary, Portland OR, USA 
R.M. Lang, Chicago IL, USA
 
    Abstract Page
 10:45  SUBSTERNAL EPICARDIAL ECHO: A NEW WINDOW TO THE POSTOPERATIVE HEART (Invited Lecture)
A.P. Furnary, R.I. Lowe, J.T. Hanlon, D.J. Sahn, Portland OR, USA 
 3
 11:00  FEASIBILITY OF USING MODIFIED ACOUSTIC QUANTIFICATION WITH ECHOCARDIOGRAPHIC CONTRAST FOR AUTOMATED ENDOCARDIAL BORDER DETECTION AND EVALUATION OF LV FUNCTION (Invited Lecture)
R.M. Lang, J.E. Bednarz, K.T. Spencer, V. Mor-Avi, Chicago, IL, USA 
 3
 11:15  DOPPLER ECHOCARDIOGRAPHY: THE NON-INVASIVE PULMONARY ARTERY CATHETER (Invited Lecture)
M.T. Saltzberg, Chicago IL, USA
  3
 11:30  DECREASED HIGH ENERGY PHOSPHATE RATIOS IN THE MYOCARDIUM OF MEN WITH DIABETES MELLITUS TYPE I
B. Metzler, M.F.H. Schocke, P. Steinboeck, C. Wolf, M. Lechleitner, P. Lukas, O. Pachinger, Innsbruck, Austria
  3
 11:45  CARDIAC FATTY ACID METABOLISM IMAGING WITH CONVENTIONAL NUCLEAR MEDICINE TECHNIQUES FOR PREDICTING OUTCOME IN PATIENTS WITH CHRONIC ISCHEMIC HEART FAILURE
A.S. Hambye, A. Dobboleir, A. Vervaet, M. Vaerenberg, J. Vandevivere, P. Vermeersch, D. Stockman, F. Van den Branden, P. Van den Heuvel, Antwerp, Belgium
  4
 12:00  CORONARY FLOW VELOCITY DISTURBANCES IN PATIENTS WITH SYNDROME X DEMONSTRATED BY DOPPLER FLOW MEASUREMENT
J. Qian, J. Ge, H. Chen, Shanghai, China 
 4
 12:15  NONINVASIVE ASSESSMENT OF CORONARY FLOW RESERVE BY TRANSTHORACIC DOPPLER ECHOCARDIOGRAPHY WITH A HIGH-FREQUENCY TRANSDUCER IN PATIENTS WITH VARIOUS HEART DISEASES
T. Hozumi, T. Akasaka, K. Yoshida, J. Yoshikawa, S. Homma, Kobe, Osaka, Japan, New York NY, USA 
 4
 12:30  PREDICTIVE VALUE OF LOW-DOSE DOBUTAMINE STRESS ECHOCARDIOGRAPHY FOR LEFT VENTRICULAR FUNCTION DYSFUNCTION AFTER HIGH-DOSE CARDIOTOXIC CHEMOTHERAPY
A. Martinoni, M. Civelli, D. Cardinale, G. Lamantia, E. Borghini, C.M. Cipolla, C. Fiorentini, Milan, Italy
  4
 12:45  COMBINED APPLICATION OF PULSED, TISSUE DOPPLER AND 2-D ECHOCARDIOGRAPHY FOR THE DETECTION OF TRANSPLANT REJECTION
J.P. Sun, G. Cheng, J. Xu, J. X. Qin, W.J. Stewart, D. Pelegrin, J.B. Young, M.J. Garcia, J.D. Thomas, Cleveland OH, USA 
 5
13:00  THE ROLE OF ECHOCARDIOGRAPHY IN HEART FAILURE (INVITED LECTURE)
Fausto J. Pinto, Lisbon, Portugal
 
 13:15  Lunch Break  
MONDAY, JULY 10, 2000
10:45-12:30   HALL C
 S51:  Session:
HEART FAILURE IN INFANCY AND CHILDHOOD, CONGENITAL HEART DISEASE
Chairpersons: M.L. Epstein, Detroit MI, USA R.D. Ross, Detroit MI, USA
 
    Abstract Page
 10:45  CATHETER CLOSURE OF ATRIAL SEPTAL DEFECTS WITH THE AMPLATZER OCCLUDER IN 80 ADULTS - AN OUTPATIENT PROCEDURE
H. Sievert, K. Horvath, E.E. Zadan, U. Krumsdorf, R. Schraeder, A. Fach, D. Scherer, R. Ensslen, H. Merle, H. Spies, H. Zeplin, Frankfurt, Germany 
 5
 11:00  LONG TERM EFFECTS OF VENTRICULAR SEPTAL DEFECTS WITH A MODERATE LEFT TO RIGHT SHUNT WITH AND WITHOUT OPERATION
M.D. Talsma, J.P.C. Jaspers, M.T.E. Bink-Boelkens, Groningen, The Netherlands
  5
 11:15  PRE-OPERATIVE ACIDOSIS IN THE NEWBORN PATIENTS PREVENTED BY PRENATAL DIAGNOSIS OF CONGENITAL HEART DISEASE
P.M. Verheijen, L.A. Lisowski, P. Stoutenbeek, J.F. Hitchcock, G.B.W.E. Bennink, J.I. Brenner, J.A. Copel, C.S. Kleinman, E.J. Meijboom, Utrecht, The Netherlands, Baltimore MD, USA 
 5
 11:30  STENT IN AORTIC COARCTATION (AoC): IMMEDIATE RESULTS AND MID-TERM FOLLOW-UP
M. Ledesma, F. David, S. Jimenez, A. Sanchez, A. Diaz, C. Benitez, R. Herrera, X. Escudero, R. Arguero, Mexico D.F., Mexico 
 6
 11:45  INCIDENCE AND TYPES OF VALVE DYSPLASIA IN 170 PULMONARY VALVULOPLASTY PROCEDURES
J. Simon-Lamuela, J. Sanmarti, J. Casaldaliga, C. Sanchez, M. Murtra, Barcelona, Spain 
 6
 12:00  RIGHT VENTRICULAR DYSFUNCTION IN PATIENTS WITH TRANSPOSITION OF THE GREAT ARTERIES: PRELIMINARY RESULTS WITH ACE INHIBITORS
R. Chugh, K. Junge, P. Romero, P. Barger, D. Kelly, P. Ludbrook, St. Louis MO, USA
  6
 12:15  MULTIPLE CARDIAC VALVE REGURGITATION IN MARFAN SYNDROME
M.C. Porciani, L. Giurlani, B. Giusti, P. Martinucci, T. Brunelli, L. Evangelisti, R. Abbate, G.F. Gensini, G. Pepe, Florence, Rome, Italy
 6 
 12:30  Lunch Break  
MONDAY, JULY 10, 2000
10:45-12:45   HALL D
  S52: Session:
ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR ANTAGONISTS
Chairpersons: S. Goldstein, Detroit MI, USA B.N. Singh, Los Angeles CA, USA
 
    Abstract Page
 10:45  SERUM ERYTHROPOIETIN LEVELS IN HEART FAILURE PATIENTS ARE TENDENTIALLY HIGHER IF THEY ARE TREATED WITH AT1 RECEPTOR ANTAGONISTS COMPARED WITH AN ACE-INHIBITOR
B. Chatterjee, U.E. Nydegger, P.J. Mohacsi, Bern, Switzerland 
 7
 11:00  CHOICE OF ACE INHIBITOR INFLUENCES ACHIEVEMENT OF TARGET DOSES IN HEART FAILURE PATIENTS
A.B. Luzier, L. DiTusa, D.M. Triller, J.L. Izzo, Jr., Buffalo NY, USA 
 7
11:15  CARDIOPROTECTION INDUCED BY ANGIOTENSIN II TYPE 1 RECEPTOR ANTAGONIST, CANDESARTAN, IS ASSOCIATED WITH INCREASED ANGIOTENSIN III TYPE 2 RECEPTOR PROTEIN BUT NOT APOPTOSIS
R. Moudgil, Y. Xu, S. Musat-Marcu, B.I. Jugdutt, Edmonton AB, Canada 
7
11:30  DISPARITY OF THERAPEUTIC HEART FAILURE GUIDELINES AND STANDARD CLINICAL PRACTICE
F. Smart, S. Battaglia, L. Tarkington, S. Culler, E. Becker, A. Simon, H.O. Ventura, New Orleans LA, USA 
7
11:45  THE CARDIOVASCULAR MORTALITY AND MORBIDITY OF CANDESARTAN IN CHF
E. Erdmann, M. George, B. Voet, G. Belcher, D. Kolb, M. Pietrek, Cologne, Mannheim, Germany, London, UK 
8
12:00  ACEI THERAPY IN CHF PATIENTS TOO ILL TO QUALIFY FOR EVIDENCE BASED CLINICAL TRIALS
K.O. Akosah, A.M. Schaper, K. Briggs, R. Sundaram, S. Devine, La Crosse WI, USA 
8
12:15  EFFECTS OF LOSARTAN VERSUS LISINOPRIL ON SYSTOLIC, DIASTOLIC AND CARDIOPULMONARY FUNCTION IN HEART FAILURE
A.C. Hunt, P. Manning, C. Denslow, M. Burrows, M.A. James, Somerset, UK 
8
 12:30  EFFECTS OF LOSARTAN ON THE QUALITY OF LIFE AND MORTALITY IN SEVERE ISCHEMIC HEART FAILURE WITH CHRONIC PULMONARY HEART DISEASE
X. Zeng, Y. Lee, X. Zeng, Chengdu, China 
 8
 12:45  Lunch Break  
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
 P101:  Poster Session:
VASCULAR BIOLOGY, ENDOTHELIAL FUNCTION
 
Board No.    Abstract Page
 1  TRANSFECTION OF AN ADENOVIRUS-MEDIATED RAS MUTANT ALL EVIATES THE RESTENOTIC LESIONS OF CORONARY ARTERY INJURY IN PIGS
C.S. Lin, C.H. Wu, C.J. Wu, R.S. Hung, Y.J. Shyy, S. Chien, S.-K. Liu, Miaoli, Taiwan-R.O.C., San Diego CA, USA 
 9
 2  FIBRINOLYTIC BALANCE DISORDERS AND ENDOTHELIAL DYSFUNCTION IN ESSENTIAL HYPERTENSION: THE EFFECT OF ACE GENOTYPE
O. Stavroulakis, A. Hatzizacharias, T. Makris, P. Krespi, G. Anastasiadis, E. Chronakis, N. Hatzizacharias, M. Kyriakidis, Athens, Greece 
 9
 3  POTENTIAL ATHEROGENIC EFFECTS OF SHORT-TERM HIGH DOSE GROWTH HORMONE TREATMENT IN THE RAT MODEL
S. Coskun, B. Ersoy, C. Sekuri, K. Ozbilgin, M. Yurtseven, A. Onag, Izmir, Turkey 
 9
 4  LIPOPROTEINS ARE TRIGGERS OF OXIDATIVE STRESS IN PATIENTS WITH DYSLIPIDEMIA
J. Eckes, B. Fink, O. Sommer, H. Weise, K. Winkler, W. Maerz, E. Bassenge, Freiburg, Germany 
 9
 5  INCREASED OXIDATIVE STRESS IN PATIENTS WITH HYPERCHOLESTEROLEMIA AND CORONARY ARTERY DISEASE IS NORMALIZED AFTER HELP APHERESIS
J. Eckes, B. Fink, O. Sommer, W. Maerz, E. Bassenge, Freiburg, Germany
  10
 6  ISCHEMIC MITRAL REGURGITATION REPAIR - PREVENTION OF CONGESTIVE HEART FAILURE
K. Golba, J. Biernat, K. Widenka, R. Mrozek, M. Deja, R. Bachowski, S. Wos, Katowice, Poland 
 10
 7  ESTIMATION OF VESSEL WALL CONDITION IN VIVO ACCORDING TO THE SPECTRUM OF TONES BY KOROTKOV
N.N. Alexandrova, V.N. Bakutsky, P.I. Romanchuk, A.N. Volobuyev, Samara, Russia
  10
 8  DIVERGENT VASOMOTOR EFFECT OF CONTRAST MEDIA ON HEALTHY AND DISEASED CORONARY
G. Musumeci, U. Limbruno, A.S. Petronio, R. Baglini, G. Paterni, R. De Caterina, R. Mariotti, M. Mariani, Pisa, Italy 
 10
THE EFFECT OF LEFT VENTRICULAR HYPERTROPHY ON FLOW-MEDIATED DILATATION OF THE BRACHIAL ARTERY
M. Zoghi, E. Ercan, C. Gurgun, C. Ceyhan, O. Yavuzgil, F. Ozerkan, A. Akilli, C. Turkoglu, M. Akin, Izmir, Turkey 
11
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P102:  Poster Session:
NEUROHORMONAL, IMMUNOLOGIC ASPECTS OF HEART FAILURE
 
Board No.   Abstract Page
 10  SEQUENTIAL NEURO-HUMORAL CHANGES IN OVINE MODEL OF SURGICALLY INDUCED HEART FAILURE
A.K. Hasnat Buckley, H.J. Kemp, M.H. Yacoub, London, UK 
 11
 11  NEUROHORMONAL CHANGES IN PATIENTS WITH ISCHEMIC HEART FAILURE AFTER 6 MONTHS OF CARDIAC REHABILITATION
B. Bacior, A. Kubinyi, W. Szot, I. Guevara, A. Zdzienicka, A. Dembinska-Kiec, K. Kawecka-Jaszcz, Krakow, Poland 
 11
 12  DOES ALDOSTERONE "ESCAPE" IN CHRONIC HEART FAILURE RELATE TO FUNCTIONAL IMPAIRMENT?
M. Cicoira, L. Zanolla, L. Franceschini, G. Brighetti, G. Golia, A. Rossi, P. Zardini, Verona, Italy 
 11
 13  MODIFIED CIRCADIAN RHYTHM OF THE IMMUNOMODULATING DEHYDROEPIANDROSTERONE-SULFATE (DHEAS) IN CORONARY ARTERY DISEASE (CAD) AND REDUCED LEFT VENTRICULAR (LV) FUNCTION
K. Gunther, M. Mueller, S. Kraemer, E. Schulze-Bahr, P. Loh, B. Brisse, Muenster, Germany 
 12
 14  INFLUENCE OF ANAPHYLACTIC SHOCK AND AGE ON THE RESERVE OF MYOCARDIAL ISOMETRIC CONTRACTILITY
Z. Senikiene, E. Stankevicius, Kaunas, Lithuania 
 12
 15  ACTIONS OF PROSTAGLANDINS (E1, F2 a) AND CYCLIC NUCLEOTIDES (cAMP, cGMP) DISTURBANCES ON THE CARDIOVASCULAR FUNCTIONS DURING PRIMARY AND REPEATED ANAPHYLACTIC SHOCK
P. Cibas, B. Ruta, J. Ivaskeviciene, R. Obeleniene, S. Rutiene, Kaunas, Lithuania 
 12
 16  ROLE OF HISTAMINE H1 AND H2 RECEPTORS IN ANAPHYLACTIC REACTION OF THE CONTRACTILE MYOCARDIUM
R. Lazauskas, Z. Senikiene, Kaunas, Lithuania
  12
17  IMPORTANCE OF NEUROHUMORAL ACTIVATION FOR THE EXPRESSION OF NA+-CA2+ EXCHANGER IN END-STAGE FAILING HUMAN MYOCARDIUM
W. Schillinger, R. Ferrari, G. Hasenfuss, Goettingen, Germany 
13
 18  THE KINETICS OF NEUROHUMORAL FACTORS IN ACUTE MYOCARDIAL INFARCTION
H. Lapp, J.P. Stasch, I. Krakau, H. Guelker, M. Mueller, Wuppertal, Germany 
 13
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P103:  Poster Session:
HEART FAILURE DUE TO CORONARY ARTERY DISEASE
 
Board No.    Abstract Page
 19  CHF HISTORY IS ASSOCIATED WITH MORE ADVANCED CORONARY DISEASE
A. Simon, F. Smart, S. Battaglia, L. Turkington, S. Culler, E. Becker, H.O. Ventura, New Orleans LA, USA 
 13
 20  PLATELET ACTIVITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND CONGESTIVE HEART FAILURE IN BACKGROUND
V.Z. Netiazhenko, O.R. Dotsenko, O.M. Plenova, T. Malchevska, O.V. Lapshin, Kyev, Ukraine
  13
 21  2 YEAR FOLLOW-UP OF PATIEN ATS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION
M.G. Glezer, I.V. Persianov-Dubrov, I.N. Sokolova, A.V. Prikhodchenko, K.E. Sobolev, Moscow, Russia 
 14
 22  A NEW INSIGHT INTO PATHOGENESIS OF HEART FAILURE IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD)
N. Mamaev, A. Gudkova, K. Amineva, O. Kovalyeva, T. Gindina, I. Bannikova, St. Petersburg, Russia 
 14
 23  ANTIPHOSPHOLIPID ANTIBODIES AND OTHER THROMBOGENIC FACTORS IN YOUNG PATIENTS WITH MYOCARDIAL INFARCTION
C. Carp, C. Ginghina, V. Uscatescu, D. Colita, D. Chesta, C. Ceck, E. Apetrei, Bucharest, Romania
  14
 24  RISK OF HEART FAILURE IN PATIENTS WITH MILD INFARCT-RELATED MITRAL REGURGITATION AFTER Q-WAVE MYOCARDIAL INFARCTION - LONG TERM FOLLOW UP
M. Zielinska, W. Koniarek, E. Kot, H. Bolinska, Lodz, Poland
  14
25  CAN HEART RATE IDENTIFY PATIENTS AT RISK FOR VENTRICULAR REMODELING AFTER SMALL TO MODERATE MYOCARDIAL INFARCTION?
G.M. Costa, C. Pizzi, G. Bedetti, R. Bugiardini, Bologna, Italy 
15
 26  MYOCARDIAL VIABILITY INDEPENDENTLY INFLUENCES LV DIASTOLIC FUNCTION AFTER ACUTE MYOCARDIAL INFARCTION
M. Cicoira, A. Rossi, G. Golia, M. Anselmi, L. Latina, P. Marino, P. Zardini, Verona, Italy
  15
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P104:  Poster Session:
ISCHEMIC CARDIOMYOPATHY
 
Board No.    Abstract Page
 27  FREE PATCH CARDIOMYOPLASTY
S.A. Taheri, H.J. Leonhardt, R. Heffner, M. Wilson, A. Grover, Buffalo NY, USA 
 15
 28  LEFT VENTRICULAR FUNCTION AND SERUM CYTOKINES LEVEL IN PATIENTS WITH CORONARY HEART DISEASE
T. Mandecki, K. Mizia-Stec, B. Zahorska-Markiewicz, J. Janowska, A. Szulc, E. Jastrzebska-Maj, L. Szymanski, Katowice, Poland 
 15
 29  PREDICTORS OF THE APPEARANS OF REAL HEART FAILURE IN CHRONIC HAEMODIALYSIS PATIENTS
M.E. Krotin, B. Milovanovic, O. Stojanovic, A. Cavalo, S. Pljesa, D. Lisulov, Belgrade, Yugoslavia 
 16
MONDAY, JULY 10, 2000
08:30-13:00   POSTER AREA
P105:  Poster Session:
LEFT VENTRICULAR HYPERTROPHY
 
Board No.    
 30  RELATION BETWEEN SEQUENTIAL MEASUREMENTS OF LEFT VENTRICULAR DIASTOLIC FILLING AND INSTANTANEOUS MEASUREMENT OF BLOOD PRESSURE BY ABPM IN PATIENTS WITH ESSENTIAL HYPERTENSION
A. Cwetsch, A. Skrobowski, M. Cholewa, G. Kaminski, K. Makowski, L. Kubik, Warsaw, Poland 
 16
 31  ECHOCARDIOGRAPHIC REFERENCE RANGES AND ECG FINDINGS IN YOUTH PROFESSIONAL SOCCER PLAYERS
J.D. Somauroo, J.R. Pyatt, M. Jackson, R.A. Perry, D.R. Ramsdale, Liverpool, UK 
 16
 32  THE INFLUENCE OF THE CORONARY CIRCULATION ON LEFT VENTRICULAR DIASTOLIC FUNCTION
M. Zhong, Y. Zhang, W. Zhang, Z. Ge, Jinan, China 
 16
 33  RELATIONSHIP BETWEEN CARDIAC VOLUME, MUSCLE MASS AND LEFT VENTRICULAR PRESSURE: A LEFT VENTRICULAR PRESSURE-VOLUME RELATIONSHIP WITH A POSSIBLE APPLICATION TO THE PHYSIOLOGY OF VENTRICULAR RESECTION IN CONGESTIVE HEART FAILURE
W. Seitz, San Francisco CA, USA 
 17
 34  BLOOD PRESSURE PROFILE IN ELDERLY PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION: RELATIONSHIP WITH LEFT VENTRICULAR HYPERTROPHY AND SILENT CEREBROVASCULAR DAMAGE
C. Moroni, M. Nanetti, C. Affricano, R. Cassone, Rome, Italy 
 17
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P105:  Poster Session:
LEFT VENTRICULAR HYPERTROPHY (cont'd)
 
Board No.    Abstract Page
 35  LEFT VENTRICULAR HYPERTROPHY: THE DILEMMA BETWEEN STRAIN AND ISCHEMIA
A.C.F. De Lara Llarena, J.D. Verzosa, F.G. Dizon, R.E. Ramboyong, Manila, Philippines
  17
36  EFFICACY OF LERCANEDIPINE VS LOSARTAN ON LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS
R. Fogari, A. Mugellini, L. Corradi, P. Preti, A. Zoppi, P. Lazzari, M. Pasotti, Pavia, Italy 
17
 37  THE TRANSESOPHAGEAL ECHOCARDIOGRAPHIC STUDIES OF RELATIONSHIP BETWEEN DIASTOLIC LEFT VENTRICULAR FUNCTION AND CORONARY BLOOD FLOW
W. Zhang, L.-L. Wei, Y. Zhang, M. Zhong, X.-P. Ji, Jinan, China 
 18
 38  INFLUENCE OF THE NIFEDIPINE ON LEFT VENTRICULAR HYPERTROPHY IN ESSENTIAL HYPERTENSIVE PATIENTS
A. Qawir Khan, Z. Ali, F. Alam, M. Alam Khan, Mingora, Pakistan 
 18
 39  REACTION OF HYPERTROPHIED MYOCARDIUM IN ESSENTIAL HYPERTENSIVE (EHTN) PATIENTS ON STRESS TEST
A. Qawir Khan, Z. Ali, F. Alam, Mingora, Pakistan 
 18
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P106:  Poster Session:
PULMONARY CIRCULATION ASPECTS, PULMONARY HYPERTENSION
 
Board No.    Abstract Page
 40  IS NON INVASIVE DIFFERENTIATION OF PRIMARY PULMONARY HYPERTENSION AND PULMONARY THROMBOEMBOLISM FEASIBLE USING TRANSTHORACIC ECHOCARDIOGRAPHY?
L. Scelsi, S. Ghio, A. Gavazzi, F. Recusani, C. Raineri, A. Repetto, A. Darmini, M. Vigano, L. Tavazzi, Pavia, Italy
 19
 41  THROMBOLYTIC THERAPY IN THE TREATMENT OF THROMBOEMBOLISM OF THE RIGHT ATRIAL CAVITY DURING PULMONARY EMBOLISM: OUR EXPERIENCE WITH rt-PA AND ONE-YEAR FOLLOW-UP WITH ECHOCARDIOGRAPHY DOPPLER
G. Pierre-Justin, M. Garrique, P. Jeanneaux, R. Beauzile, Fort de France (Martinique), France 
 19
MONDAY, JULY 10, 2000
08:30-13:00 
 
POSTER AREA
P106:  Poster Session:
PULMONARY CIRCULATION ASPECTS, PULMONARY HYPERTENSION (cont'd)
 
Board No.    Abstract Page
 42  PULMONARY BLOOD FLOW DISTRIBUTION AFTER THE TOTAL CAVOPULMONARY CONNECTION
M. Tayama, N. Hirata, T. Matsushita, N. Fukushima, Y. Sawa, H. Matsuda, Osaka, Japan 
 19
 43  CONTINUOUS EPOPROSTENOL INFUSION IN PRIMARY AND SECONDARY PULMONARY HYPERTENSION; A PRELIMINARY EXPERIENCE
C. Campana, A. Gavazzi, L. Scelsi, S. Ghio, A. Repetto, M. Ceresa, A. Fontana, L. Tavazzi, Pavia, Italy 
 19
 44  INCIDENCE OF CHEYNE-STOKES RESPIRATION IN PATIENTS WITH DIFFERENT KINDS OF HEART FAILURE
M. Rossi, M. Contini, P. Moruzzi, Milan, Italy 
 20
 45  SUCCESSFUL TREATMENT OF RIGHT HEART THROMBOEMBOLI (RHT) WITH IV rtPA: FOLLOW-UP AT 12 MONTHS
G. Pierre-Justin, M. Garrigue, P. Jeanneaux, R. Beauzile, Fort de France (Martinique), France 
 20
 46  S-NITROSOGLUTATHIONE IS A PROMISING NITRIC OXIDE DONOR FOR THE TREATMENT OF EXPERIMENTAL RAT PULMONARY HYPERTENSION
J. Kobayashi, M. Sonoda, T. Miyazaki, E. Hirakawa, M. Takezawa, T. Seiya, S. Masutani, M. Nogaki, H. Senzaki, T. Kobayashi, T. Komoda, Tokyo, Japan 
 20
MONDAY, JULY 10, 2000
08:30-13:00   POSTER AREA
 P107:  Poster Session:
HEART FAILURE IN SYSTEMIC DISEASE
 
Board No.   Abstract Page
 47  DIFFERENCES IN RIGHT VENTRICULAR DIASTOLIC FUNCTION BETWEEN PATIENTS WITH b-THALASSEMIA MAJOR WITH NORMAL AND ABNORMAL LEFT VENTRICULAR SYSTOLIC FUNCTION
I. Moyssakis, E. Voskaridou, P. Voyatzi, D. Drosos, G. Anastasiadis, M. Kyriakidis, D. Loukopoulos, Athens, Greece 
 20
48  BLOOD PRESSURE PROFILE IN ACROMEGALICS: EFFECTS OF TRANSSPHENOIDAL SURGERY
C. Moroni, G. Minniti, M.L. Jaffrain Rea, M. Nanetti, C. Affricano, G. Tamburrano, R. Cassone, Rome, L'Aquila, Italy 
21
 49  MYOCARDIAL INJURY IN ENTERIC FEVERS
M. Sharma, M. Bhutani, V.K. Sharma, H.K. Aggarwal, N. Nand, Rohtak, India 
 21
MONDAY, JULY 10, 2000
08:30-13:00    POSTER AREA
P107:  Poster Session:
HEART FAILURE IN SYSTEMIC DISEASE (cont'd)
 
Board No.   Abstract Page
 50  EVOLUTION OF CARDIAC LESIONS IN SYSTEMIC SCLEROSIS
I. Moyssakis, V. Vasiliou, F. Triposkiadis, G. Anastasiadis, D. Drosos, M. Kyriakidis, Athens, Greece
  21
 51  ECHOCARDIOGRAPHIC EVALUATION OF 117 CHILDHOOD CANCER LONG TERM SURVIVORS
G. Bossi, L. Lanzarini, M.L. Laudisa, C. Klersy, A. Ricci, A. Raisaro, M. Arico, Pavia, Italy 
 21
 52  CARDIAC MANIFESTATIONS IN ANKYLOSING SPONDYLITIS
I. Moyssakis, E. Batzoglou, V. Vasiliou, F. Triposkiadis, M. Kyriakidis, Athens, Greece
 22 
 53  LOW-DOSE DOBUTAMINE ECHO STRESS FOR EVALUATION OF ASYMPTOMATIC LONG-TERM SURVIVORS OF CHILDHOOD CANCER
G. Bossi, A. Raisaro, C. Klersy, M. Arico, M.L. Laudisa, V.S. Russotto, Pavia, Italy
 22 
MONDAY, JULY 10, 2000
08:30-13:00   POSTER AREA
P108:  Poster Session:
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME
 
Board No.    Abstract Page
 54  CHANGES OF CARDIAC TROPONIN T FOLLOWING COMBINATION OF DAUNORUBICIN WITH NEW ANTINEOPLASTIC DRUGS
M. Adamcova, V. Gersl, J. Machackova, R. Hrdina, M. Melka, M. Nobilis, V. Mazurova, Hradec Kralove, Czech Republic
  22
 55  FREQUENCY AND PREDICTORS OF IMPROVEMENT OF LV FUNCTION IN PATIENTS WITH "PURE" IDIOPATHIC DCM
M. Cicoira, L. Zanolla, L. Latina, A. Rossi, G. Golia, G. Brighetti, P. Zardini, Verona, Italy 
 22
 56  COMPARISON OF HOSPITAL LENGTH OF STAY AND READMISSION RATE BETWEEN PATIENTS WITH PRESERVED AND DECREASED LEFT VENTRICULAR FUNCTION
Q. Malki, N.D. Sharma, A. Afzal, K. Ananthsubramaniam, A. Abbas, G. Jacobson, S. Jafri, Detroit MI, USA 
 23
 57  FAS SERUM LEVELS ARE NOT INCREASED IN CACHECTIC HEART FAILURE PATIENTS
G. Filippatos, K. Tsilias, K. Venetsanou, J. Koutras, D. Manolatos, E. Karambinos, D. Economou, A. Kranidis, N. Sfougaris, F. Kardaras, L. Anthopoulos, G. Baltopoulos, Athens, Greece
 23 
 58  PEAK CARDIAC POWER OUTPUT PREDICTS PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE
S.G. Williams, G.A. Cooke, D.J. Wright, W. Parsons, L.B. Tan, Leeds, UK
 23 
MONDAY, JULY 10, 2000
14:00-15:45   HALL A
PL03:  Plenary Session:
ARRHYTHMIAS AND CARDIAC PACING
M.E. Cain, St. Louis MO, USA Abstract Page
C.T. Peter, Los Angeles CA, USA
 
 14:00  ARRHYTHMIA RELATED HEART FAILURE IN CHILDREN - EVALUATION AND MANAGEMENT (Invited Lecture)
M.L. Epstein, Detroit MI, USA 
 23
 14:15  ATRIAL FIBRILLATION - CHALLENGES FOR THE CLINICIAN (Invited Lecture)
C.T. Peter, Los Angeles, CA, USA
  24
 14:30  ELECTROPHYSIOLOGIC MECHANISMS UNDERLYING VENTRICULAR ARRHYTHMIAS IN PATIENTS WITH NONISCHEMIC CARDIOMYOPATHY (Invited Lecture)
M.E. Cain, S.M. Pogwizd, St. Louis MO, USA 
 24
 14:45  NEW DEVELOPMENTS FOR THE PHARMACOLOGIC THERAPY OF CARDIAC ARRHYTHMIAS IN HEART FAILURE (Invited Lecture)
B.N. Singh, Los Angeles CA, USA 
 24
 15:00  BETA BLOCKER THERAPY: WHAT HAVE WE LEARNED FROM THE RECENT CLINICAL TRIALS (Invited Lecture)
S. Goldstein, Detroit MI, USA 
 24
 15:15  MECHANISM OF VENTRICULAR TACHYCARDIA IN HEART FAILURE: IMPORTANCE OF THE UNDERLYING DISEASE AND IMPLICATIONS FOR MANAGEMENT (Invited Lecture)
J.L. Merino, Madrid, Spain 
 25
15:30  IMPACT OF SHORT-TERM CHRONIC VENTRICULAR STIMULATION ON EXERCISE TOLERANCE AND WELL-BEING IN CHF: RESULTS OF PATH-CHF TRIAL
A. Auricchio, C. Stellbrink, S. Sack, M. Block, J. Vogt, P. Bakker, P. Mortensen, F. Schondube, U. Wolfhard, D. Boecker, O. Kranefeld, H. Kirkels, Magdeburg, Germany 
25
 15:45  Coffee Break  
MONDAY, JULY 10, 2000
14:00-16:15   HALL B
PL04:  Plenary Session:
ASSESSMENT OF MYOCARDIAL FUNCTION: CLINICAL SIGNIFICANCE AND PROGNOSTIC IMPLICATIONS
Chairpersons: R. Shabetai, San Diego CA, USA 
A.J. Tajik, Rochester MN, USA
 
    Abstract Page
 14:00  DIASTOLOGY 2000: GRADING AND PROGNOSTIC IMPLICATIONS OF DIASTOLIC DYSFUNCTION (Invited Lecture)
A.J. Tajik, Rochester MN, USA
  25
 14:15  DIASTOLIC DYSFUNCTION AS A CAUSE OF EXERCISE INTOLERANCE (Invited Lecture)
W.C. Little, D.W. Kitzman, C.-P. Cheng, Winston-Salem NC, USA 
 25
 14:30  LEFT VENTRICULAR REMODELING IN HYPERTENSION (Invited Lecture)
P.R. Liebson, Chicago IL, USA 
 26
 14:35  DIFFERENT MECHANISMS UNDERLIE RESPIRATORY VARIATION OF HEMODYNAMICS IN CONSTRICTION VERSUS TAMPONADE (Invited Lecture)
R. Shabetai, San Diego CA, USA 
 26
 15:00  LOOKING FOR THE SIGNAL OF LIFE: LOW VERSUS HIGH COST TECHNIQUES IN PATIENTS WITH ISCHEMIC HEART FAILURE (Invited Lecture)
P. Marzullo, Pisa, Italy 
 26
 15:15  VALUE OF NUCLEAR IMAGING IN ASSESSING CARDIAC INVOLVEMENT IN MYOTONIC DYSTROPHY (Invited Lecture)
D. Agostini, Caen, France 
 26
 15:30  CLINICAL SIGNIFICANCE OF MYOCARDIAL VIABILITY IN HEART FAILURE DUE TO CORONARY ARTERY DISEASE (Invited Lecture)
C.A. Visser, Amsterdam, The Netherlands
  27
 15:45  NUCLEAR CARDIAC IMAGING IN ASSESSING INITIAL RISK AND GUIDING THERAPEUTICS OF PATIENTS POST MYOCARDIAL INFARCTION (Invited Lecture)
J.J. Mahmarian, Houston TX, USA 
27 
 16:00  IMAGING OF BLOOD FLOW AND METABOLISM WITH POSITRON EMISSION TOMOGRAPHY (PET) FOR THE DETECTION OF VIABLE MYOCARDIUM IN INFANTS AND CHILDREN
M. Hernandez Pampaloni, V. Allada, M.C. Fishbein, H.R. Schelbert, Los Angeles CA, USA 
27 
 16:15  Coffee Break  
MONDAY, JULY 10, 2000
14:00-16:15    HALL C
S53:  Session:
VASCULAR BIOLOGY, ENDOTHELIAL FUNCTION
Chairpersons: H. Schroeder, Halle (Saale), Germany 
M. Vanderheyden, Aalst, Belgium
 
  Abstract Page
 14:00  THE PROGNOSTIC IMPACT OF NITRIC OXIDE IN TX RECIPIENTS AND IN PATIENTS WITH DILATED CARDIOMYOPATHY (Invited Lecture)
M. Vanderheyden, Aalst, Belgium
 27 
 14:15  MECHANISM OF CALCIUM HANDLING INDUCED BY SIMVASTATIN IN CULTURED BOVINE AORTIC ENDOTHELIAL CELLS
M. Alvarez de Sotomayor, E. Marhuenda, R. Andriantsitohaina, Seville, Spain, Illkirch, France 
 28
 14:30  IN VIVO PROTEIN KINASE C INHIBITION PREVENTS NOS III UNCOUPLING AND NORMALIZES ENDOTHELIAL DYSFUNCTION IN AN ANIMAL MODEL OF DIABETES MELLITUS
H. Mollnau, U. Hink, M. Oelze, T. Munzel, Hamburg, Germany 
28 
 14:45  TISSUE ENDOTHELIN-CONVERTING ENZYME ACTIVITY CORRELATES WITH CARDIOVASCULAR RISK FACTORS IN CORONARY ARTERY DISEASE
F.T. Ruschitzka, U. Moehrlen, T. Quaschning, G. Noll, M. Lachat, M. Turina, T.F. Luescher, Zuerich, Switzerland 
 28
15:00  ROLE OF NITRIC OXIDE IN CARDIAC AND VASCULAR ADAPTIONS FOLLOWING MYOCARDIAL INFARCTION IN RATS
V. da Cunha, M. da Gloria S. Gomes, I. Stafanos, J.G. Mill, Vitoria, Brazil 
28
15:15  DOES ASCORBIC ACID SUPPLEMENTATION IMPROVE ENDOTHELIAL DYSFUNCTION IN CORONARY MICROCIRCULATION IN PATIENTS WITH RISK FACTORS FOR CORONARY ARTERY DISEASE?
T.H. Schindler, M. Mix, I. Brink, N. Magosaki, E. Nitzsche, Freiburg, Germany
 29
15:30  ROLE OF MACROPHAGE SCAVENGER RECEPTORS IN DIET-INDUCED ATHEROSCLEROSIS IN MICE
H. Sakaguchi, M. Takeya, S. Horiuchi, K. Takahashi, Makinimato, Kumamoto, Japan
 29
15:45  AN IN VITRO STUDY ON THE ANTIOXIDANT CAPACITY OF STATINS
F. Franzoni, F. Regoli, F. Galetta, Pisa, Italy
 29
16:00  PATHOBIOLOGIC ROLE OF HYPERFIBRINOGENEMIA IN CAROTID PLAQUE DESTABILIZATION
L.G. Spagnoli, G. Sangiorgi, G. Palmieri, R. Virmani, D.R. Holmes, R.S. Schwartz, S. Fratoni, A. Mauriello, Rome, Italy, Washington DC, Rochester MN, USA
 29
16:15  Coffee Break  
MONDAY, JULY 10, 2000
14:00-16:00   HALL D
S54:  Session:
EPIDEMIOLOGY AND CLINICAL ASPECTS OF HEART FAILURE
Chairpersons: U. Goldbourt, Maywood Illinois, USA 
B. Stanek, Vienna, Austria
 
    Abstract Page
 14:00  CONSULTATIONS BETWEEN GENERALISTS AND CARDIOLOGISTS: ASSOCIATION WITH QUALITY OF CARE FOR OLDER ADULTS HOSPITALIZED WITH HEART FAILURE (HF)
A. Ahmed, R.M. Allman, J.F. DeLong, Birmingham AL, USA
  30
 14:15  HEART RATE, PROINSULIN AND FATTY ACIDS ARE PREDICTORS OF LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN A MALE POPULATION AFTER TWENTY YEARS OF FOLLOW-UP
J.B. Arnlov, L. Lind, B. Zethelius, B. Andren, B. Vessby, Uppsala, Sweden
 30 
 14:30  INCREASE IN HOSPITAL ADMISSION RATES BUT NOT IN MORTALITY FOR HEART FAILURE IN THE CZECH REPUBLIC, 1986-1997
J. Bruthans, J. Holub, D. Dzurova, Prague, Czech Republic
 30 
 14:45  OUTCOMES OF PATIENTS WITH HEART FAILURE IN ACUTE CORONARY SYNDROMES WITHOUT ST ELEVATION: PROSPECTIVE REGISTRY OF ACUTE ISCHAEMIC SYNDROMES IN THE UK (PRAIS-UK)
M.C. Shibata, J.R. Collinson, A. Bakhai, M.D. Flather, K.A.A. Fox, London, UK
 30 
 15:00  THE SWISS HEART FAILURE-REGISTRY
S. Zbinden, O.M. Hess, P. Mohacsi, Bern, Switzerland
 31 
 15:15  IMPACT OF THE CHF CLINIC ON THE DELIVERY OF OPTIMAL PATIENT CARE TO PATIENTS IN NOVA SCOTIA, CANADA
J.G. Howlett, A. Svenon, D.E. Johnstone, J. Cox, Halifax NS, Canada
 31 
 15:30  COST-EFFECTIVENESS OF HIGH VS LOW DOSE ACEi IN CHF: AN ECONOMIC ANALYSIS OF THE ATLAS STUDY
J.S. Schwartz, Y. Wang, J. Cleland, Philadelphia PA, USA, Hull, UK
  31
15:45  SPECIALITY-RELATED DIFFERENCES IN THE CLINICAL PROFILE AND MANAGEMENT OF PATIENTS HOSPITALIZED FOR HEART FAILURE: THE OSCUR STUDY
P. Bellotti, L. Badano, P. Bernabo, N. Acquarone, G. Lo Pinto, C. Mattiauda, R. Griffo, E. Haupt, Genoa, Italy
 31
 16:00  Coffee Break  
MONDAY, JULY 10, 2000
16:15-18:30   HALL A
PL05:  Plenary Session:
CORONARY ARTERY DISEASE: PATHOPHYSIOLOGY AND CLINICAL ASPECTS
Chairpersons: J.S. Forrester, Los Angeles CA, USA M. Gheorghiade, Chicago IL, USA
 
    Abstract Page
 16:15  CHRONIC HEART FAILURE DUE TO CORONARY ARTERY DISEASE: EVALUATION AND MANAGEMENT, UPDATE 2000 (Invited Lecture)
M. Gheorghiade, Chicago IL, USA
 32 
 16:30  STATINS: EFFICACY, SAFETY AND PLEIOTROPIC EFFECTS IN THE MANAGEMENT OF CORONARY HEART DISEASE (Invited Lecture)
J.S. Forrester, Los Angeles CA, USA
 32 
 16:45  MICROVASCULAR DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASES (Invited Lecture)
J. Ge, J. Qian, D. Baumgart, M. Haude, R. Erbel, Shanghai, China, Essen, Germany
 32 
 17:00  EFFECTS OF VENTRICULAR VOLUME AND MYOCARDIAL CONTRACTILITY ON CORONARY MICROCIRCULATION (Invited Lecture)
A. L'Abbate, D. Neglia, M.G. Trivella, Pisa, Italy
 32 
 17:15  AUTOPRECONDITIONING IN EARLY MYOCARDIAL INFARCTION (Invited Lecture)
R.N.A. Gasser, Graz, Austria
 33 
 17:30  DIAGNOSIS AND MANAGEMENT OF HIBERNATING MYOCARDIUM (Invited Lecture)
A. Lahiri, Harrow, Middlesex, UK
 33 
17:45  HOW IMPORTANT IS ISCHEMIA IN MORTALITY FROM ISCHEMIC CARDIOMYOPATHY: RESULTS FROM THE ATLAS TRIAL (Invited Lecture)
Barry F. Uretsky, Galveston TX, USA
 33
 18:00  THE FACTORS THAT PREDISPOSE PATIENTS WITH CHD AND HEART FAILURE TO THE INCIDENCE OF STROKE (Invited Lecture)
U. Goldbourt, N. Koren, D. Tanne, Tel-Hashomer, Israel
 33 
18:15  THE RATIONALE OF MAGNESIUM AS ANTITHROMBOTIC TREATMENT FOR PATIENTS WITH CORONARY ARTERY DISEASE (Invited Lecture)
M. Shechter, Tel Aviv, Israel
 34
MONDAY, JULY 10, 2000
16:15-19:00   HALL B
S55:  Session:
MYOCARDITIS AND CARDIOMYOPATHIES
Chairpersons: N.J. Angomachalelis, Thessaloniki Macedonia, Greece
P.P. Liu, Canada Abstract Page
 
 16:15  MANIPULATION AND UNDERSTANDING OF HOST FACTORS IN MYOCARDITIS (Invited Lecture)
P.P. Liu, Toronto Ontario, Canada
 34 
 16:30  RELATIONSHIP BETWEEN TROPONIN I RELEASE AND LEFT VENTRICULAR DYSFUNCTION AFTER HIGH DOSE CHEMOTHERAPY
D. Cardinale, M.T. Sandri, A. Tricca, A. Martinoni, G. Lamantia, M. Civelli, E. Cocorocchio, G. Martinelli, C.M. Cipolla, C. Fiorentini, Milan, Italy
 34 
 16:45  NEGATIVE FORCE-FREQUENCY RELATIONSHIP IN IDIOPATHIC DILATED CARDIOMYOPATHY BUT NOT IN ISCHEMIC CARDIOMYOPATHY
I.P. Clements, L.J. Olson, W.L. Miller, Rochester MN, USA
 34 
17:00  PLASMA FIBRINOGEN AS A RISK FACTOR FOR EMBOLISM IN PATIENTS WITH DILATATIVE CARDIOMYOPATHY
D. Planinc, I.D. Gabric, V. Erdeljic, K. Starnbuk, B. Raic, B. Starcevic, Zagreb, Croatia
 35
 17:15  PERMANENT DDD PACING IMPROVES DIASTOLIC FUNCTION IN THE SEVERE OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
J. Tascon, A. Albarran, R. Gascuena, F. Hernandez, M. Alonso, J. Andreu, M. Velazquez, R. Dalmau, M. Pombo, Madrid, Spain
 35 
 17:30  CLINICAL PROFILE AND OUTCOME OF IDIOPATHIC RESTRICTIVE CARDIOMYOPATHY
N.M. Ammash, A.J. Tajik, Rochester MN, USA 
 35
 17:45  GIANT CELL MYOCARDITIS AS A MANIFESTATION OF DRUG HYPERSENSITIVITY
P.R. Daniels, G.J. Berry, H.D. Tazelaar, L.T. Cooper, Rochester MN, Stanford CA, USA 
 35
 18:00  HEMODYNAMIC CHARACTERISTICS OF MECHANICAL PULSUS ALTERNANS IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY
A. Kirashiki, H. Ishihara, H. Kanda, Okazaki, Japan
 36 
 18:15  DIGITALIS-LIKE IMMUNOREACTIVE SUBSTANCES IN PLASMA ANDMYOCARDIUM OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
T. Hayashi, H. Shimomura, Y. Kitaura, Osaka, Japan 
 36
 18:30  INDUCTION OF CARDIOMYOPATHY IN SEVERE COMBINED IMMUNODEFICIENCY MICE BY TRANSFER OF LYMPHOCYTES FROM PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY
E. Omerovic, E. Bollano, V. Kujacic, B. Andersson, F. Waagstein, A. Hjalmarson, M. Fu, Goteborg, Sweden 
 36
 18:45  ELECTROCARDIOGRAPHIC MARKERS IN PATIENTS WITH ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA. A COMPARISON WITH HEALTHY SUBJECTS
D. Poci, N. Edvardsson, Goteborg, Sweden
  36
MONDAY, JULY 10, 2000
16:15-18:45   HALL C
 S56:  Session:
NEUROHORMONAL IMUNOLOGIC ASPECTS OF HEART FAILURE, NATRIURETIC PEPTIDES, ENTOTHELIN
Chairpersons: J.L. Mehta, Gainesville FL, USA I.H. Zucker, Omaha NE, USA
 
    Abstract Page
 16:15  NEW OPTIONS FOR THE TREATMENT OF ACUTE HEART FAILURE: BRAIN NATRIURETIC PEPTIDES AND ENDOTHELIN RECEPTOR ANTAGONISTS
U. Elkayam, Los Angeles CA, USA
 
 16:30  BIOCHEMICAL DETECTION OF LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS
E. Kazzam, T. Hedner, A. Waldenstrom, Eskilstuna, Goteborg, Umea, Sweden 
 37
 16:45  DNP - AN ENDOTHELIAL CELL DERIVED MEMBER OF THE NATRIURETIC PEPTIDE FAMILY
D.M. Heublein, H. Leskinen, A. Cataliotti, M. Jougasaki, O. Lisy, J.C. Burnett Jr., Rochester MN, USA 
 37
17:00  N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN CONGESTIVE HEART FAILURE
M. Haass, R. Kell, C. Zugck, A. Feist, F. Chwallek, W. Kuebler, Heidelberg, Germany 
37
 17:15  VALUE OF PLASMA BIG ENDOTHELIN AND PRO- ANP TO PREDICT RAPID WORSENING OF HEART FAILURE IN COMPARISON TO A STANDARD WALK TEST AND HEART FAILURE QUESTIONNAIRE
J. Bergler-Klein, R. Pacher, B. Frey, A. Bojic, D. Mueller, M. Quittan, B. Stanek, Vienna, Austria 
 37
 17:30  EFFECTS OF AN ENDOTHELIN ETA/ETB RECEPTOR ANTAGONIST (ENRASENTAN) ON CARDIAC REMODELING, HEMODYNAMICS AND SURVIVAL IN THE SHRSP-HSHF MODEL
K.M. Anderson, F.C. Barone, A.H. Nelson, A.R. Olzinski, N. Aiyar, T. Woods, R. Coatney, E.H. Ohlstein, R.N. Willette, King of Prussia PA, USA 
 38
17:45  CLINICAL, HEMODYNAMIC AND NEUROHUMORAL EFFECTS OF CHRONIC SELECTIVE ETA RECEPTOR BLOCKADE IN CONGESTIVE HEART FAILURE (HEAT, HEART FAILURE ETA RECEPTOR BLOCKADE TRIAL)
F.T. Ruschitzka, G. Noll, V. Mitrovic, R. Pacher, M. Schulze, W. Kiowski, Zuerich, Switzerland 
38
18:00  SHORT TERM EFFECTS OF ENDOTHELIN RECEPTOR BLOCKADE IN CONGESTIVE HEART FAILURE UNDER CHRONIC ANGIOTENSIN II TYPE 1 RECEPTOR ANTAGONISM
K. Dohi, K. Onishi, T. Kitamura, N. Isaka, T. Nakano, Tsu, Japan 
38
18:15  NEUROHORMONAL ACTIVATION CORRELATES WITH CELLULAR AND CLINICAL MARKERS OF LEFT VENTRICULAR DYSFUNCTION IN PATIENTS WITH CHRONIC MITRAL REGURGITATION
J. Hooper, L. Moran, M. Kemp, D.L. Adamson, I.O. Brookes, S.E. Harding, N. Moat, London, UK 
38
18:30  HOST VARIABILITY IN CYTOMEGALOVIRUS MEDIATED INDUCTION OF INTERFERON g BY CD8 T LYMPHOCYTES: A POSSIBLE ROLE OF THE IMMUNE SYSTEM IN CONVEYING RESISTANCE OR SENSITIVITY TO THE EFFECTS OF INFECTION ON THE PATHOGENESIS OF ATHEROSCLEROSIS
F. Khan, M. Panelli, F. Marincola, S.E. Epstein, Washington DC, USA 
39
MONDAY, JULY 10, 2000
16:15-17:30   HALL D
S57:  Session:
HYPERTENSION, LVH AND PULMONARY ASPECTS
Chairpersons: P.R. Liebson, Chicago IL, USA 
P. Lund-Johansen, Bergen, Norway
 
    Abstract Page
16:15  IMPROVEMENT OF LEFT VENTRICULAR MASS AND DIASTOLIC FUNCTION IN ACROMEGALICS AFTER SUCCESSFUL TRANSSPHENOIDAL SURGERY
C. Moroni, G. Minniti, M.L. Jaffrain Rea, M. Nanetti, C. Affricano, V. Esposito, G. Tamburrano, R. Cassone, Rome, L'Aquila, Italy 
39
16:30  RELATIONSHIP OF LEFT VENTRICULAR HYPERTROPHY AND LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION IN DOBUTAMINE STRESS ECHOCARDIOGRAPHY
A.S.K. Kwong, C.K. Chan, W.L. Chan, L.K. Chan, K.Y. Kan, S.Y. Tse, O.L. Law, H.S. Chan, Hong Kong, China 
39
 16:45  ADRENOMEDULLIN DELAYS THE DEVELOPMENT OF PULMONARY HYPERTENSION
P. Vijay, T.G. Sharp, J.W. Brown, Indianapolis IN, USA 
 39
 17:00  LATE ONSET OF PULMONARY HYPERTENSION FOLLOWING SUCCESSFUL MUSTARD SURGERY FOR TRANSPOSITION OF THE GREAT ARTERIES
E.S. Ebenroth, R.A. Hurwitz, Indianapolis IN, USA 
 40
 17:15  SILDENAFIL IS A PULMONARY VASODILATOR WHICH AUGMENTS AND PROLONGS VASODILATATION BY INHALED NITRIC OXIDE IN PATIENTS WITH PULMONARY HYPERTENSION
J.J. Lepore, A. Maroo, L. Ginns, L.M. Bigatello, C.W. Dec, R. Rubin, W.M. Zapol, K.D. Bloch, M.J. Semigran, Boston MA, USA 
 40
MONDAY, JULY 10, 2000
18:45-22:10   HALL A
SS:  Satellite Symposium:
ELECTRICAL MODULATION OF CARDIAC CONTRACTILITY IN HEART FAILURE: THE IMPULSE DYNAMICS™ SIGNAL
This symposium is organized by Impulse Dynamics, Inc.
Chairpersons: S. Goldstein, Detroit MI, USA
H.N. Sabbah, Detroit MI, USA
 
 18:30  REGISTRATION AND RECEPTION  
 19:20  TREATMENT OF HEART FAILURE IN 2000: AN OVERVIEW
S. Goldstein, Detroit MI, USA
 
19:40  TREATMENT OF HEART FAILURE: THE PACING APPROACH
A. Natale, Cleveland OH, USA
 
 20:00  MODULATION OF VENTRICULAR CONTRACTILITY WITH THE IMPULSE DYNAMICS™ SIGNAL: THEORY & MECHANISM
D. Burkhoff, New York NY, USA
 
 20:30  CARDIAC CONTRACTILITY MODULATION: EFFECTS ON GLOBAL CARDIAC FUNCTION
D.J. Callans, Philadelphia PA, USA
 
 20:50  APPLICATION OF THE IMPULSE DYNAMICS™ SIGNAL IN-VIVO: PRE-CLINICAL STUDIES IN ANIMALS WITH HEART FAILURE
H.N. Sabbah, Detroit MI, USA
 
 21:20  INITIAL HUMAN SAFETY STUDIES WITH THE IMPULSE DYNAMICS™ CARDIAC CONTRACTILITY MODULATION SIGNAL
C. Pappone, Milan, Italy
 
 21:50  PANEL DISCUSSION:
Faculty
 
MONDAY, JULY 10, 2000
13:30-18:00   POSTER AREA
P201:  Poster Session:
MOLECULAR BIOLOGY, BASIC RESEARCH
 
Board No.    Abstract Page
 1  ENDOTHELIN-1 PRODUCED AND SECRETED FROM MYOCARDIUM IS MORE AUGMENTED IN ISCHEMIC THAN IN NONISCHEMIC HEART DISEASE
A. Namiki, M. Ishikawa, T. Kubota, M. Fukazawa, M. Moroi, J. Aikawa, K. Ebine, T. Yamaguchi, Tokyo, Japan 
 40
 2  DIFFERENTIAL SCREENING CAPTOPRIL RESPONSIVE GENE IN THE HEART OF SPONTANEOUSLY HYPERTENSIVE RATS
Z. Zhu, Y. Liu, Y. Xu, X. Meng, B. Zhao, S. Zhu, Chongquing, Beijing, China 
 40
CHANGES AND SIGNIFICANCE OF CIRCULATORY ENDOTHELIN LEVEL DURING CORONARY ARTERY BYPASS SURGERY
J.C. Wang, S. Wen, Q. Zhou, Beijing, China 
41
 4  EFFECTS OF CARDIAC GLYCOSIDES ON CANINE CARDIAC SR CA RELEASE CHANNELS
T. Sagawa, T. Naka, T. Sato, H. Watanabe, G. Endo, Y. Maruyama, T. Isshiki, Tokyo, Japan
  41
ENTEROVIRAL INFECTION AND RESERVOIR IN PERIPHERAL MUSCLE OF PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY
E. Porcu, M. Grasso, F. Magani, E. Arbustini, Pavia, Italy 
41
 6  MITOCHONDRIAL DNA MUTATION AS A CAUSE OF HEART FAILURE
T. Obayashi, A. Tanaka, M. Hibino, Y. Hayashi, Y. Nishimoto, T. Ishii, Y. Yamanaka, S. Sumino, Y. Suzuki, Kariya, Japan
  41
MONDAY, JULY 10, 2000
13:30-18:00    POSTER AREA
P202:  Poster Session:
INFLAMATORY MEDIATORS IN HEART FAILURE
 
Board No.    
 7  CYTOKINES IN INFECTIVE ENDOCARDITIS UNDER ANTIBIOTIC TREATMENT - A NEW DIAGNOSTIC PARAMETER?
P. Alter, J. Hoeschen, B. Maisch, Marburg/Lahn, Germany 
 42
 8  THE TNF-a SYSYEM IN HEART FAILURE AND AFTER HEART TRANSPLANTATION: PLASMA PROTEIN LEVELS, mRNA EXPRESSION, SOLUBLE RECEPTORS AND PLASMA BUFFER CAPACITY
C.C. Baan, I.C. van Riemsdijk-van Overbeeke, H.G.M. Niesters, C.J. Hesse, E.H.M. Loonen, A.P.W.M. Maat, A.H.M.M. Balk, W. Weimar, Rotterdam-Dijkzigt, The Netherlands 
 42
 9  LATE DIAGNOSIS OF KAWASAKI DISEASE IS ASSOCIATED WITH HAPTOGLOBIN PHENOTYPE
W.-C. Lee, K.-P. Hwang, Y.-T. King, H.-C. Chen, S.-S. Chiou, R.C. Yang, T.-Y. Huang, Miaoli, Taiwan-R.O.C. 
 42
MONDAY, JULY 10, 2000
13:30-18:00   POSTER AREA
P202:  Poster Session:
INFLAMATORY MEDIATORS IN HEART FAILURE (cont'd)
 
Board No.    Abstract Page
 10  CYTOKINES ACTIVITY AND CARDIAC DYSFUNCTION IN CHRONIC HEART FAILURE
O. Kovalyova, T. Asheulova, Kharkov, Ukraine 
 42
11  EFFECTS OF ASTRAGALOSIDE IV INJECTION ON SERUM TUMOR NECROS FACTOR a AND INTERFORO g IN CHRONIC HEART FAILURE
X. Zeng, Y. Huang, X. Zeng, Chengdu, China
 43
 12  USE OF SERUM EOSINOPHIL CATIONIC PROTEIN (ECP) AS A MARKER OF ACTIVATION IN EOSINOPHILIC ENDOMYOCARDIAL DISEASE (EMD)
M. Arima, T. Kanoh, Y. Kawano, T. Oigawa, S. Yamagami, S. Matsuda, Urayasu-shi, Japan
 43 
MONDAY, JULY 10, 2000
13:30-18:00    POSTER AREA
 P203:  Poster Session:
HYPERTROPHIC CARDIOMYOPATHY
 
 Board No.    
 13  IMPROVEMENT IN DIASTOLIC FUNCTION DURING DDD PACING IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
J. Tascon, A. Albarran, F. Hernandez, R. Gascuena, M. Alonso, J. Andreu, M. Velazquez, M. Pombo, R. Dalmau, Madrid, Spain
  43
 14  LEFT ATRIAL OVERLOAD IN ELECTROCARDIOGRAM IN PATIENTS WITH DILATED PHASE OF HYPERTROPHIC CARDIOMYOPATHY
T. Yamano, S. Hirasaki, M. Yokoi, K. Yamamoto, T. Sawada, A. Azuma, M. Nakagawa, Kyoto, Japan
 43 
 15  NEW FEATURES OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY BY MEANS OF TRANSTHORACIC ECHOCARDIOGRAPHY
M. Yokoi, S. Hirasaki, T. Nakamura, T. Yamano, T. Sawada, A. Azuma, M. Nakagawa, Kyoto, Japan 
 44
 16  INHIBITORS OF ACE IN NONOBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY (HCM)
V. Tseluiko, O. Kovalevskaya, Y. Gorb, I. Krays, A. Tsigankov, Kharkov, Ukraine
 44 
 17  HEART FAILURE IN PATIENTS WITH DIFFERENT ECHOMORPHOLOGIC FORMS OF OBSTRUCTIVE AND NON OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
N. Kipshidze, K. Liluashvili, M. Rogava, M. Okujava, L. Jijeishvili, A. Kochlamazashvili, Tbilisi, Georgia
 44 
 18  ECHOCARDIOGRAPHIC ASSESSMENT IN PIGS WITH SPONTANEOUSLY OCCURRING HYPERTROPHIC CARDIOMYOPATHY
J.-H. Lin, S.-Y Huang, S.-K. Liu, W.-C. Lee, R. Chu, Miaoli, Taipei, Taiwan-R.O.C., New York NY, USA 
 44
MONDAY, JULY 10, 2000
13:30-18:00    POSTER AREA 
 P204:  Poster Session:
PREVENTIVE ASPECTS OF HEART FAILURE
 
Board No.   Abstract Page 
 19  EFFECTS OF LIPOPHILIC ANTIOXIDANT TRILINOLEIN ON SUPEROXIDE DISMUTASE ACTIVITY AND MRNA IN CULTURED AORTIC SMOOTH MUSCLE CELLS (A7R5)
P. Chan, J.-T. Cheng, Taipei, Tainan, Taiwan-R.O.C. 
 45
 20  HOME TELEMONITORING FOR PREVENTION OF CHF EXACERBATION
T.M. Nanevicz, D.A. Zipkin, M.C. Serlin, S.C. Ennis, J.D. Piette, San Francisco CA, USA 
 45
 21  REDUCED INCIDENCE OF CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH THEOPHYLLINE PLUS NIFIDIPINE GITS IN SICK SINUS SYNDROME
Y. Lee, X. Zeng, J. Ja, Y. Huang, Chengdu, China 
 45
 22  RESULTS OF CONTROLLED PHYSICAL TRAINING PROGRAM ON PATIENTS WITH POST-ISCHEMIC CHRONIC HEART FAILURE
P. Bara, G. Ndrepepa, B. Pocesta, F. Shatri, Tirana, Albania 
 45
 23  SOME MECHANISMS OF PREVENTION OF DEVELOPMENT REFRACTORY HEART FAILURE BY NITRATE WITH LOSARTAN + HEPTRAL FROM NEUROHUMORAL POINT OF VIEW
A.O. Shushlyapin, O.V. Mysnytchenko, O.I. Shushlyapin, Kharkov, Ukraine 
 46
MONDAY, JULY 10, 2000
13:30-18:00     POSTER AREA
 P205:  Poster Session:
EPIDEMIOLOGY OF HEART FAILURE
 
Board No.    Abstract Page 
 24  PREVALENCE OF CHRONIC HEART FAILURE IN PORTUGAL. A COMMUNITY-BASED STUDY: EPICA study
F. Ceia, C. Fonseca, T. Mota, F. Matias, H. Morais, A. Sousa, G. Oliveira, Lisbon, Portugal 
 46
 25  DIASTOLIC HEART FAILURE IN A GENERAL HOSPITAL: A GROWING PROBLEM
J.S. Espinosa-Caliani, J.J. Gomez-Doblas, L. Lopez, A. Montijano, J.M. Garcia-Pinilla, J. Robledo, F. Cabrera, M. Ruiz, M.F. Jimenez, F.J. Perez-Lanzac, E. de Teresa, Malaga, Spain 
 46
 26  SCREENING FOR HEART FAILURE IN THE COMMUNITY BY THE ECG AND THE CHEST X-RAY
T. Mota, C. Fonseca, F. Matias, H. Morais, A. Sousa, G. Oliveira, F. Ceia, Lisbon, Portugal 
 46
MONDAY, JULY 10, 2000
13:30-18:00    POSTER AREA 
 P205:  Poster Session:
EPIDEMIOLOGY OF HEART FAILURE (cont'd)
 
Board No.    Abstract Page 
 27  PREVALENCE AND AETIOLOGY OF CONGESTIVE HEART FAILURE CASES ADMITTED TO UNIVERSITY HOSPITAL, KUALA LUMPUR, MALAYSIA
S.M. Wong, B.T. Teh, A. Robiah, W. Azman, S. Thuraisingham, A.M. Choy, K.H. Tan, P. Jesudason, K.S. Chua, R.B. Herman, C.C. Lang, Kuala Lumpur, Malaysia
 47
 28  VALIDATION AND PERFORMANCE OF QUESTIONNAIRES FOR THE DIAGNOSIS OF HEART FAILURE IN THE PORTUGUESE POPULATION
C. Fonseca, T. Mota, F. Matias, H. Morais, A. Sousa, G. Oliveira, F. Ceia, Lisbon, Portugal 
 47
 29  MANAGEMENT OF HEART FAILURE IN PORTUGUESE PRIMARY CARE
F. Ceia, T. Mota, C. Fonseca, F. Matias, H. Morais, A. Sousa, G. Oliveira, Lisbon, Portugal 
 47
MONDAY, JULY 10, 2000
13:30-18:00   POSTER AREA 
 P206:  Poster Session:
RENAL ASPECTS, DIURETICS
 
 Board No   Abstract Page
 30  SPIRONOLACTONE AS ADDITIONAL THERAPY IN PATIENTS WITH AORTO-CORONARY BYPASS SURGERY AND SEVERE HEART FAILURE
L. Georgievska-Ismail, V. Borozanov, S. Jovanova, S. Georgievski, T. Caparoska, Skopje, Macedonia 
 47
 31  LEFT VENTRICULAR FUNCTIONS AND LIPID PEROXIDATION IN CHRONIC RENAL FAILURE
N. Nand, M. Sharma, S. Suri, Rohtak, India
  48
MONDAY, JULY 10, 2000
13:30-18:00   POSTER AREA
 P207:  Poster Session:
DIGOXIN AND OTHER NEW INOTROPIC AGENTS IN HEART FAILURE
 
Board No.    Abstract Page 
 32  DIGITALIS GLYCOSIDES AS INDUCERS OF PROGRAMMED CELL DEATH
M. Ramirez, J. Melendez, V. Maldonado, J. Suarez, G. Pastelio, Mexico D.F., Mexico 48
 
 33  OUTPATIENT INFUSION OF POSITIVE INOTROPES: ROLE OF BIOIMPEDANCE, NONINVASIVE HEMODYNAMIC MONITORING - (BioZ)
C. Kumbar, G. Choudhary, R. Vrushab, E. Fayn, C. Antonio, V. Just, W.A. Clark, M.A. Papp, Chicago IL, USA 48
 
 34  THE ROLE OF CARNITINE IN THE TREATMENT OF VENTRICULAR SYSTOLIC DYSFUNCTION
L. Iliuta, V. Candea, A. Vasilescu, D. Gherghiceanu, H. Moldovan, B. Radulescu, R. Vasile, C. Macarie, Bucharest, Romania 
48 
 35  DOBUTAMINE AMBULATORY THERAPY IN CHRONIC HEART FAILURE; EFFICACY AND SAFETY OF CONTINUOUS INFUSION MODE
C. Campana, A. Giusti, L. Scelsi, A. Fontana, S. Ghio, A. Gavazzi, L. Tavazzi, Pavia, Italy 
49 
 36  THE TREATMENT OF PERIOPERATIVE HEART FAILURE IN CARDIAC SURGERY WITH CREATINE PHOSPHATE
V. Candea, I. Tintoiu, A. Popa, V. Rosu, V. Murgu, D. Arhire, O. Lazar, D. Lachy, I. Iliuta, T. Somacescu, Bucharest, Romania
  49
 37  PLASMA LEVELS AND URINARY EXCRETION OF OUABAIN LIKE COMPOUND IN CARDIOVASCULAR DISEASES
F. Horkay, M. Toth, M. Beck, I. Szokodi, P. Turbucz, K. Szalay, J. Leppaluoto, R. DeChatel, Budapest, Hungary
  49
MONDAY, JULY 10, 2000
13:30-18:00    POSTER AREA 
 P208:  Poster Session:
CALCIUM CHANNEL BLOCKERS IN HEART FAILURE
 
Board No.    Abstract Page 
 38  ELECTROPHYSIOLOGICAL PROPERTIES OF LERCANIDIPINE
P. Bara, G. Ndrepepa, F. Shatri, B. Pocesta, E. Shota, Tirana, Albania 
 49
 39  CALCIUM ANTAGONISTS IN DIASTOLIC DYSFUNCTION OF PATIENTS WITH RESIDUAL ISCHEMIA IN LATE POSTINFARCTION PERIOD
V. Bobrov, M. Dolzhenko, Y. Bobrova, Kiev, Ukraine 
 50
 40  EFFECTS OF AMLODIPINE ON HEART RATE VARIABILITY AND QT DISPERSION IN PATIENTS WITH ESSENTIAL HYPERTENSION
I. Zarkos, G. Livieratos, P. Sinnis, E.A. Thireos, Athens, Crete, Greece 
 50
MONDAY, JULY 10, 2000
13:30- 18:00    POSTER AREA
 P209:  Poster Session:
APPROACH TO THE PATIENT WITH SYNCOPE
 
Board No.    Abstract Page 
 41  CLINICAL NEUROMEDIATED SYNCOPE: RISK FACTORS FOR SYNCOPE RECURRENCE AFTER TILT-TABLE TESTING IN UNTREATED PATIENTS
G. Foglia Manzillo, M. Comelli, G. Corrado, G. Tadeo, L.M. Tagliagambe, M. Spata, M. Santarone, Como, Pavia, Italy 
 50
 42  EFFECTS OF ETILEFRINE IN THE TREATMENT OF PATIENTS WITH RECURRENT VASOVAGAL SYNCOPE
F. Giada, A. Raviele, A. Corrado, M. Brignole, R. Sutton, P. Alboni, P. Giani, C. Menozzi, A. Moya, Mestre-Venezia, Italy 
 50
 43  LONG TERM SERTRALINE TREATMENT IN PATIENTS WITH NEUROCARDIOGENIC SYNCOPE
A. Pinar, M. Yesil, M.H. Dinckal, U.A. Turk, S. Bayata, N. Postaci, Izmir, Turkey
  51
MONDAY, JULY 10, 2000
13:30-18:00    POSTER AREA
P210:  Poster Session:
ADVANCES IN CONGENITAL HEART DISEASE
 
Board No.    
44  EARLY RESULTS OF THE ROSS PROCEDURE IN CHILDREN WITH CONGENITAL LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION
J.W. Brown, M. Ruzmetov, Y. Okada, M.W. Turrentine, Indianapolis IN, USA
 51
45  TRANSCATHETER CLOSURE OF THE PATENT DUCTUS ARTERIOSUS (PDA) WITH THE AMPLATZER OCCLUDER IN ADULTS
H. Sievert, E. Maus, H. Spies, A. Fach, D. Scherer, H. Zeplin, Frankfurt, Germany 
51
46  MORTALITY AND MORBIDITY OF BICUSPID AORTIC VALVE
C. Ward, M. Hall, UK
 51
47  PREVALENCE OF BICUSPID AORTIC VALVE IN CHILDREN: A POPULATION STUDY
M. Boschello, C. Perone, A. Cera, A. Mecenaro, C. Marchiori, E. De Dominicis, G. Thiene, Vicenza, Italy 
52
48  OWN EXPERIENCES WITH THROMBOLYTIC THERAPY WITH RT- PA IN CHILDREN WITH PERIPHERAL VESSELS THROMBOSES AND PULMONARY EMBOLISM
G. Kowalik, E. Wiatrowska, K. Kubicka, W. Kawalec, G. Brzezinska, J. Ksiazyk, M. Tomyn, B. Maruszewski, P. Burczynski, H. Lukasiewicz, Warsaw, Poland 
52
49 PREVALENCE, RISK FACTORS AND CONSEQUENCES OF HEART FAILURE AFTER FONTAN PROCEDURE
S.B. Zaets, I. Yurlov, M. Zelenikin, N. Katsadze, M. Ruzmetov, Moscow, Russia, Indianapolis IN, USA 
52
50  IMPACT OF PREGNANCY IN PULMONARY VASCULAR DISEASE. MATERNAL AND FETAL OUTCOMES
W.S. Avila, M. Grinberg, E.G. Rossi, A.A. Lopes, P.L. da Luz, J.A.F. Ramires, Sao Paulo, Brazil 
52
MONDAY, JULY 10, 2000
13:30-18:00    POSTER AREA
P211: Poster Session:
SURGICAL REVASCULARIZATION
 
Board No.   Abstract Page
51  ROUTINE MINIMAL INVASIVE VEIN HARVESTING REDUCES POSTOPERATIVE MORBIDITY IN CARDIAC BYPASS PROCEDURES. CLINICAL REPORT OF 2000 PATIENTS
R. Coppoolse, W. Rees, H. Warnecke, Bad Rothenfelde, Germany 
53
52  ASSESSMENT OF SPLANCHNIC PERFUSION IN OPEN HEART SURGERY BY "ONLINE" MEASUREMENT OF ISCHEMIA-RELATED PARAMETER
H.-G. Wollert, H. Grubitzsch, T. Wenzel, L. Eckel, M. Wendt, Karlsburg, Germany 
53
53  CHANGES IN LEFT VENTRICULAR SYSTOLIC AND DIASTOLIC PERFORMANCE DURING CORONARY BYPASS SURGERY
M. Satsuki, I. Hitoshi, K. Hirofumi, K. Makoto, S. Akira, Okazaki, Japan 
53
54  EFFECT OF POSTERIOR PERICARDIOTOMY ON POSTOPERATIVE SUPRAVENTRICULAR ARRHYTHMIAS AND LATE PERICARDIAL EFFUSION (POSTERIOR PERICARDIOTOMY)
E. Kuralay, E. Ozal, U. Demirkilic, H. Tatar, Ankara, Turkey 
53
MONDAY, JULY 10, 2000
13:30- 18:00   POSTER AREA
P212:  Poster Session:
ISSUES SURROUNDING HEART VALVE SURGERY
 
Board No.   Abstract Page
55  IS MITRAL VALVE REPAIR ALWAYS NEEDED IN PATIENTS WITH MODERATE TO SEVERE SECONDARY MITRAL REGURGITATION MODERING AORTIC VALVE REPLACEMENT?
L. Iliuta, C. Macarie, D. Gherghiceanu, H. Moldovan, B. Radulescu, A. Vasilescu, A. Carp, M. Rotareasa, V. Candea, Bucharest, Romania
 54
56  EFFECT OF SURGICAL THERAPY ON AORTIC VALVE STENOSIS (AS) IN ELDERLY PATIENTS (>70 YEARS OLD): COMPARISON WITH MEDICAL THERAPY
A. Hashimoto, Y. Nishimura, Y. Ohtsubo, K. Kido, K. Yoshida, T. Ogata, S. Tsuji, T.M. Natsuaki, T. Ito, Saga, Japan
 54